Back to All Events Learnings from Agomab's recent $208m NASDAQ IPO Friday 24 April 2026 19:00 20:00 Google Calendar ICS With David Epstein. Previous Previous 5 March Board Chair perspectives on Agomab's $200m NASDAQ IPO Next Next 27 May China as a Board-level Conversation: How to evaluate, diligence and execute
Learnings from Agomab's recent $208m NASDAQ IPO Friday 24 April 2026 19:00 20:00 Google Calendar ICS With David Epstein.